Skip to main content

Anti-2019-nCoV(S1)-1 IgM antibody

Reference: PTXCOV-A542
size

100µg

Isotype

IgM

Brand

ProteoGenix

Product type

COVID-19 products

Clonality

Monoclonal Antibody

Product nameAnti-2019-nCoV(S1)-1 IgM antibody
SpeciesHuman
Expression systemMammalian
Molecular weight150kDa
Purity90%
BufferPBS, pH7,5
FormLiquid
Delivery conditionBlue ice (+4°C)
Storage condition4°C for short term; -20°c or -80°C for long term
BrandProteogenix
ReferencePTXCOV-A542
NoteFor research use and in vitro diagnostic only. Not suitable for human use.
IsotypeIgM
ClonalityMonoclonal Antibody
TargetRecombinant spike protein - RBD domain

Description of Anti-2019-nCoV(S1)-1 IgM antibody

General information on Anti2019-nCoV-(S1)-1

Proteogenix has developed neutralizing antibodies against 2019-nCOV (as named by WHO when SARS-CoV-2 begun to spread). The Anti-2019-nCoV-(S1)-1 antibody is an IgM isotype, especially targeting the S1 part of the Spike protein. This product is a human-origin monoclonal antibody expressed in a mammalian system, which has been validated in binding assays and infection assays. The molecular weight is 150 kDa.

About Spike targeting

The spike protein is a transmembrane viral fusion protein. Spike has a homotrimeric structure and each monomere is composed of two subunits: S1 and S2. The S1 part is carrying the Receptor Binding Domain (RBD), and the S2 part is responsible of the fusion of the virus with the cellular membrane. The RBD Part of S1 is binding the Angiotensin Converting Enzyme 2 (ACE2) in the organism.

Immunoglobulin M-type

It is a non-specific immunoglobulin of adaptive immunity. Indeed, secretion does not require the intervention of a helper T lymphocyte. They exist in 2 structural forms in the human organism: secreted or embedded in cell membrane. If secreted, IgM are circulating as a typical pentameric structure.
Proteogenix launched a panel of antibodies against SARS-CoV-2 spike and the nucleocapsid. Every of them can recognize specifically SARS-CoV-2 antigens without cross reactivity with other human coronaviruses. Neutralizing antibodies are very promising in antiviral defense against the coronavirus disease 2019 (COVID-19) pandemic. This product is suitable for all immunological methods. Research use only.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Anti-2019-nCoV(S1)-1 IgM antibody”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products